Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis

Autoimmune hepatitis (AIH) is a disorder of unknown etiology in which immune-mediated liver damage progresses to cirrhosis or hepatocellular carcinoma (HCC). The mainstay therapy for AIH is steroids and other immunosuppressive treatments. Currently, there are no validated markers for monitoring immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuoka, Naoki, Kozuru, Hideko, Koga, Tomohiro, Abiru, Seigo, Yamasaki, Kazumi, Komori, Atsumasa, Fujita, Yuya, Tenmoku, Junpei, Asano, Tomoyuki, Sato, Shuzo, Suzuki, Eiji, Furuya, Makiko, Kobayashi, Hiroko, Watanabe, Hiroshi, Naganuma, Atsushi, Yoshizawa, Kaname, Shimada, Masaaki, Ario, Keisuke, Yamashita, Haruhiro, Kohno, Hiroshi, Kaneyoshi, Toshihiko, Nakamura, Minoru, Furukawa, Hiroshi, Takahashi, Atsushi, Kawakami, Atsushi, Ohira, Hiromasa, Yatsuhashi, Hiroshi, Migita, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736219/
https://www.ncbi.nlm.nih.gov/pubmed/31464928
http://dx.doi.org/10.1097/MD.0000000000016924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736219/
https://www.ncbi.nlm.nih.gov/pubmed/31464928
http://dx.doi.org/10.1097/MD.0000000000016924

Ejemplares similares